NEW YORK, March 27 - Micromass MS Technologies has sold its inorganic mass-spectrometry business to a newly formed British company created for the sole purpose of manufacturing and selling the instruments, the company said today.
Registering provides access to this and other free content.
Already have an account?Login Now.
In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.
A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.
Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.
Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.